Derived from Current Agreements, our editors have selected notable big biotech deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.
For comprehensive access to all life science deals as they are announced:
Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now
Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now
Featured big biotech deals
All big biotech deals: Deal Monitor | Current Agreements
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
bridiedurcan : August 10, 2015 3:58 PM : Big biotech, Big pharma, Biotech, Deals, Partnering, PharmaAn interview with Richard Brudnick, Senior VP, Corporate Development, Biogen
De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration. more »
MorphoSys has acquired all outstanding shares of the Dutch biopharmaceutical company Lanthio Pharma B.V. more »
Alexion Pharmaceuticals have entered into a definitive agreement pursuant to which Alexion will acquire Synageva for consideration of $115 in cash and 0.6581 Alexion shares, for each share of Synageva, implying a total per share value of $230 based on the nine day volume-weighted average closing price of Alexion stock through May 5, 2015. more »
Celgene acquires Quanticel Pharmaceuticals
Steve Poile : April 28, 2015 6:37 AM : Big biotech, Big pharma, M&ACelgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel more »
MedImmune and Immunocore partner for melanoma combinations
Steve Poile : April 20, 2015 10:25 AM : Big biotech, Biotech, PartneringImmunocore will conduct a Phase Ib/II clinical trial combining checkpoint inhibitors MEDI4736 (anti-PD-L1) and/or tremelimumab (anti-CTLA-4) with IMCgp100 more »
Mesoblast banks $45mn financing from Celgene
Steve Poile : April 14, 2015 11:40 AM : Big biotech, FinancingMesoblast has entered into an Agreement with Celgene more »
Morphosys regains MOR202 rights from Celgene
Steve Poile : March 27, 2015 10:31 AM : Big biotech, Big pharma, Biotech, PartneringMorphoSys has regained rights to MOR202 from Celgene more »
Celgene and Open Monoclonal Tech in OmniAb alliance
Steve Poile : March 12, 2015 4:06 PM : Big biotech, Big pharma, PartneringOpen Monoclonal Technology announced license that provides Celgene with unlimited access to OMT’s proprietary OmniRat, OmniMouse and OmniFlic platforms for generation of human antibody therapeutics more »
MedImmune partners with Joslin for diabetes
Steve Poile : March 12, 2015 4:00 PM : Big biotech, Big pharma, Partnering, PharmaMedImmune and Joslin Diabetes Center announced a three-year research collaboration to develop new medicines for the treatment of diabetes, obesity, and related metabolic disorders more »
Alexion and Blueprint partner on activated kinase target
Steve Poile : March 4, 2015 12:29 PM : Big biotech, PartneringBlueprint Medicines announced a strategic collaboration with Alexion to discover, develop and commercialize novel drug candidates more »
Derived from Current Agreements, more featured partnering deals by category:
Big pharma
Pfizer creates breaking news with Allergan purchase
November 23, 2015
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Pharma
Pfizer creates breaking news with Allergan purchase
November 23, 2015
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Biotech
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Veracyte banks $40 million private placement
April 28, 2015
MedImmune and Immunocore partner for melanoma combinations
April 20, 2015
Diagnostics
Ventana and Astellas in automated tissue diagnostics pact
April 15, 2015
Roche acquires Signature Diagnostics for access to translational oncology and genomics
February 12, 2015
Personalis gains $33 million series C
January 14, 2015
Medical device
Abbott to distribute Sekiui’s coagulation testing solutions
April 15, 2015
Mallinckrodt acquires Ikaria for $2.3bn
March 5, 2015
Drug delivery
Sanofi Pasteur and VBI Vaccines in formulation pact
April 9, 2015